• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信号转导和转录激活因子3(STAT3)在肺癌发生和生长中的不同作用。

Differential roles of STAT3 in the initiation and growth of lung cancer.

作者信息

Zhou Jingjiao, Qu Zhaoxia, Yan Shapei, Sun Fan, Whitsett Jeffrey A, Shapiro Steven D, Xiao Gutian

机构信息

University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

出版信息

Oncogene. 2015 Jul;34(29):3804-3814. doi: 10.1038/onc.2014.318. Epub 2014 Oct 6.

DOI:10.1038/onc.2014.318
PMID:25284582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4387125/
Abstract

Signal transducer and activator of transcription 3 (STAT3) is linked to multiple cancers, including pulmonary adenocarcinoma. However, the role of STAT3 in lung cancer pathogenesis has not been determined. Using lung epithelial-specific inducible knockout strategies, we demonstrate that STAT3 has contrasting roles in the initiation and growth of both chemically and genetically induced lung cancers. Selective deletion of lung epithelial STAT3 in mice before cancer induction by the smoke carcinogen, urethane, resulted in increased lung tissue damage and inflammation, K-Ras oncogenic mutations and tumorigenesis. Deletion of lung epithelial STAT3 after establishment of lung cancer inhibited cancer cell proliferation. Simultaneous deletion of STAT3 and expression of oncogenic K-Ras in mouse lung elevated pulmonary injury, inflammation and tumorigenesis, but reduced tumor growth. These studies indicate that STAT3 prevents lung cancer initiation by maintaining pulmonary homeostasis under oncogenic stress, whereas it facilitates lung cancer progression by promoting cancer cell growth. These studies also provide a mechanistic basis for targeting STAT3 to lung cancer therapy.

摘要

信号转导及转录激活因子3(STAT3)与包括肺腺癌在内的多种癌症相关。然而,STAT3在肺癌发病机制中的作用尚未明确。利用肺上皮特异性诱导敲除策略,我们证明STAT3在化学诱导和基因诱导的肺癌起始和生长过程中具有相反的作用。在通过烟雾致癌物乌拉坦诱导小鼠患癌之前,选择性敲除肺上皮细胞中的STAT3会导致肺组织损伤和炎症增加、K-Ras致癌突变及肿瘤发生。肺癌形成后敲除肺上皮STAT3会抑制癌细胞增殖。在小鼠肺中同时敲除STAT3并表达致癌性K-Ras会加剧肺损伤、炎症及肿瘤发生,但会减缓肿瘤生长。这些研究表明,STAT3通过在致癌应激下维持肺内稳态来预防肺癌起始,而通过促进癌细胞生长来推动肺癌进展。这些研究还为将STAT3作为肺癌治疗靶点提供了机制基础。

相似文献

1
Differential roles of STAT3 in the initiation and growth of lung cancer.信号转导和转录激活因子3(STAT3)在肺癌发生和生长中的不同作用。
Oncogene. 2015 Jul;34(29):3804-3814. doi: 10.1038/onc.2014.318. Epub 2014 Oct 6.
2
Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer.白细胞介素-6可预防肺癌的起始,但会促进其进展。
Cancer Res. 2015 Aug 15;75(16):3209-15. doi: 10.1158/0008-5472.CAN-14-3042. Epub 2015 Jun 29.
3
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.信号转导和转录激活因子3(STAT3)信号通路的破坏促进KRAS诱导的肺癌发生。
Nat Commun. 2015 Mar 3;6:6285. doi: 10.1038/ncomms7285.
4
Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).Foxm1 转录因子对于致癌性 Kras(G12D.)引发的肺肿瘤发生是必需的。
Oncogene. 2014 Nov 13;33(46):5391-6. doi: 10.1038/onc.2013.475. Epub 2013 Nov 11.
5
Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.Gprc5a 缺失通过引发自分泌白血病抑制因子诱导的持续 Stat3 信号,增强正常和恶性肺上皮细胞中的转化表型。
Cancer Res. 2010 Nov 1;70(21):8917-26. doi: 10.1158/0008-5472.CAN-10-0518. Epub 2010 Oct 19.
6
Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis.信号转导子和转录激活子 3 在致癌物诱导的肺癌发生过程中对肿瘤免疫的抑制作用。
Cancer Res. 2012 Jun 15;72(12):2990-9. doi: 10.1158/0008-5472.CAN-11-4062. Epub 2012 Jun 1.
7
IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.白细胞介素6阻断可重编程肺肿瘤微环境以限制K-ras突变型肺癌的发生和进展。
Cancer Res. 2016 Jun 1;76(11):3189-99. doi: 10.1158/0008-5472.CAN-15-2840. Epub 2016 Apr 1.
8
Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer.雌激素与 Stat3/NF-κB 驱动的肺癌免疫调节之间的相互作用。
Carcinogenesis. 2020 Nov 13;41(11):1529-1542. doi: 10.1093/carcin/bgaa064.
9
Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer.KRAS 突变型肺癌中 STAT3 丝氨酸磷酸化的致癌依赖性
Oncogene. 2022 Feb;41(6):809-823. doi: 10.1038/s41388-021-02134-4. Epub 2021 Dec 3.
10
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer.上皮细胞 STAT3 信号在 K-ras 突变型肺癌发病机制中的性别特异性作用。
Nat Commun. 2018 Nov 2;9(1):4589. doi: 10.1038/s41467-018-07042-y.

引用本文的文献

1
Unraveling the role of STAT3 in Cancer Cachexia: pathogenic mechanisms and therapeutic opportunities.解析信号转导和转录激活因子3(STAT3)在癌症恶病质中的作用:致病机制与治疗机遇
Front Endocrinol (Lausanne). 2025 Jul 9;16:1608612. doi: 10.3389/fendo.2025.1608612. eCollection 2025.
2
Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity.对经典STAT3信号通路的选择性抑制可抑制K-ras突变型肺癌的发生,并恢复抗肿瘤免疫力。
Front Immunol. 2025 Apr 28;16:1575181. doi: 10.3389/fimmu.2025.1575181. eCollection 2025.
3
Organoid modeling reveals the tumorigenic potential of the alveolar progenitor cell state.

本文引用的文献

1
Critical analysis of the potential for targeting STAT3 in human malignancy.靶向人恶性肿瘤 STAT3 的潜力的批判性分析。
Onco Targets Ther. 2013 Jul 30;6:999-1010. doi: 10.2147/OTT.S47903. Print 2013.
2
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.IL-6/JAK/Stat3 正反馈环驱动肿瘤发生和转移。
Neoplasia. 2013 Jul;15(7):848-62. doi: 10.1593/neo.13706.
3
Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.Stat3 抑制剂 Stattic 表现出强大的抗肿瘤活性,并诱导鼻咽癌的化疗和放疗敏感性。
类器官建模揭示了肺泡祖细胞状态的致瘤潜力。
EMBO J. 2025 Mar;44(6):1804-1828. doi: 10.1038/s44318-025-00376-6. Epub 2025 Feb 10.
4
Overexpression of IL-6 and STAT3 may provide new insights into ovine pulmonary adenocarcinoma development.白细胞介素-6(IL-6)和信号转导与转录激活因子3(STAT3)的过表达可能为绵羊肺腺癌的发展提供新的见解。
BMC Vet Res. 2025 Jan 20;21(1):29. doi: 10.1186/s12917-024-04429-6.
5
Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2.通过纳米PDLIM2改善PD-1阻断联合化疗实现肺癌完全缓解
Elife. 2024 Dec 24;12:RP89638. doi: 10.7554/eLife.89638.
6
NF-κB1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice.NF-κB1 缺失促进巨噬细胞来源的肾上腺肿瘤,但减少 HTLV-I LTR-Tax 转基因小鼠的神经纤维瘤。
PLoS One. 2024 May 9;19(5):e0303138. doi: 10.1371/journal.pone.0303138. eCollection 2024.
7
IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.肿瘤相关巨噬细胞中的 IL6-STAT3-C/EBPβ-IL6 正反馈环促进肺腺癌的 EMT 和转移。
J Exp Clin Cancer Res. 2024 Feb 29;43(1):63. doi: 10.1186/s13046-024-02989-x.
8
Critical and distinct roles of cell type-specific NF-κB2 in lung cancer.细胞类型特异性 NF-κB2 在肺癌中具有关键而独特的作用。
JCI Insight. 2024 Feb 22;9(4):e164188. doi: 10.1172/jci.insight.164188.
9
Nanoparticle-Mediated Delivery of STAT3 Inhibitors in the Treatment of Lung Cancer.纳米颗粒介导的信号转导和转录激活因子3(STAT3)抑制剂递送在肺癌治疗中的应用
Pharmaceutics. 2022 Dec 13;14(12):2787. doi: 10.3390/pharmaceutics14122787.
10
Dynamic Expression of EpCAM in Primary and Metastatic Lung Cancer Is Controlled by Both Genetic and Epigenetic Mechanisms.EpCAM在原发性和转移性肺癌中的动态表达受遗传和表观遗传机制共同控制。
Cancers (Basel). 2022 Aug 25;14(17):4121. doi: 10.3390/cancers14174121.
PLoS One. 2013;8(1):e54565. doi: 10.1371/journal.pone.0054565. Epub 2013 Jan 29.
4
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
5
STAT3 negatively regulates thyroid tumorigenesis.STAT3 负向调节甲状腺肿瘤的发生。
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):E2361-70. doi: 10.1073/pnas.1201232109. Epub 2012 Aug 13.
6
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.PDLIM2 限制 Th1 和 Th17 分化,防止自身免疫性疾病。
Cell Biosci. 2012 Jun 25;2(1):23. doi: 10.1186/2045-3701-2-23.
7
First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.首例用于头颈部肿瘤的 STAT3 诱饵寡核苷酸的人体试验:对癌症治疗的启示。
Cancer Discov. 2012 Aug;2(8):694-705. doi: 10.1158/2159-8290.CD-12-0191. Epub 2012 Jun 20.
8
Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis.信号转导子和转录激活子 3 在致癌物诱导的肺癌发生过程中对肿瘤免疫的抑制作用。
Cancer Res. 2012 Jun 15;72(12):2990-9. doi: 10.1158/0008-5472.CAN-11-4062. Epub 2012 Jun 1.
9
Expression and prognostic relevance of STAT3 and cyclin D1 in non-small cell lung cancer.STAT3 和 cyclin D1 在非小细胞肺癌中的表达及预后相关性。
Int J Biol Markers. 2012 Jul 19;27(2):e132-8. doi: 10.5301/JBM.2012.9146.
10
Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma.II 型细胞作为 K-Ras 诱导的远端肺腺癌起源细胞的证据。
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4910-5. doi: 10.1073/pnas.1112499109. Epub 2012 Mar 12.